Hitachi Capital’s commercial vehicles arm has
signed a deal to supply 36 LCVs and HCVs to the National Health
Service’s blood and transplant unit.
The blue light Ford Focus estates are divided
between dry freight and refrigerated 3.5- and 7.5-tonne vehicles,
and funded on three- or five-year leases.
Go deeper with GlobalData
The deal will help Hitachi Capital to cement
its position in public sector leasing, a market it first entered
five years ago.
Mike MacDougall, Hitachi Capital Commercial
Vehicle Services head of sales, said: “We have an industry
specialist, Alan Mountain, who works just with the public sector
and has been in the industry for 10 years. We moved into the public
sector when he joined us and we’ve been working with local
authorities in the main.”
The funder last year secured a place on the
framework agreement of procurement body Buying Solutions, which
took over commercial vehicle leasing for the NHS in 2009.
The latest deal was arranged through Buying
Solutions’ framework for contract hire of commercial vehicles,
conversions and trailers. Six other suppliers are on the list,
including Automotive Leasing and ING Car Lease UK.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataLarry Bannon, fleet manager for the blood and
transplant unit, the largest commercial vehicle operator within the
NHS, said: “Hitachi Capital’s inclusion in the Buying Solutions
agreement was important, as it meant that we didn’t have to conduct
a full tender process, which can be costly and time-consuming.
Hitachi Capital got the basics right, informing us of progress
every step of the way and advising us on new initiatives.”
The new vehicles will be used to transport
blood and blood components from donors to patients. Hitachi Capital
will also be responsible for their safe decommissioning.
